MCW Pancreatic Cancer Symposium: Advancing Precision Medicine

Milwaukee, WI US
August 21, 2026

The Medical College of Wisconsin Pancreatic cancer symposium: Advancing Precision Medicine will be held on Friday, August 21, 2026. The symposium will take place at the Medical College of Wisconsin in the Hub for Collaborative Medicine, Room A1015/1035. The aim of the symposium is to provide updates on the developments of pancreatic cancer research and clinical care.

Target Audience

  • Surgeons (Surgical Oncologists, General Surgeons, Residents, and Fellows)
  • Medical Oncologists
  • Gastroenterologists
  • Advanced Practice Providers
  • Radiation Oncologists

Learning Objectives

Participants who engage in this educational intervention will be able to:

  • Evaluate emerging KRAS-directed therapies and precision medicine approaches in pancreatic cancer and apply current evidence to treatment selection and clinical management.
  • Differentiate the therapeutic implications of specific KRAS variants and incorporate molecular heterogeneity into targeted therapy and clinical trial decision-making.
  • Apply molecular profiling and circulating tumor assay results to personalize treatment strategies and identify appropriate clinical trial opportunities for patients with pancreatic cancer.
Additional information
AttachmentSize
PDF icon AUG 21 Panc Symp Brochure (1).pdf20.24 MB

Contact

Name: 
Melissa Mena
Phone Number: 
+1 (414) 955-1835
Email: 
[email protected]

Course summary

Available credit: 
  • 3.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.75 Hours of Participation
    Hours of Participation credit.
Course opens: 
06/26/2026
Course expires: 
09/29/2026
Event starts: 
08/21/2026 - 12:00pm CDT
Event ends: 
08/21/2026 - 4:45pm CDT
Cost:
$0.00
Add to calendar: 

12:00 PM Lunch - Registration, Exhibitors

Session I

12:30 PM Welcome & Introduction Douglas B. Evans, MD
12:35 PM Expanding Precision Therapeutic Frontiers in Pancreatic Cancer Wungki Park, MD, MS
1:25 PM The Evolving Therapeutic Landscape of RAS Inhibition in Pancreatic Ductal Adenocarcinoma Tommy McFall, PhD | David Seo, MD
1:50 PM The Paradox of Plenty: Decision-Making in the Age of Targeted PDAC Therapy Mandana Kamgar, MD, MPH
2:15 PM Questions and Brief Break

Session II

2:30 PM Progress Towards Earlier Detection of Pancreatic Cancer: End of the Beginning? Marcus Tan, MD
3:15 PM Emerging Role of ctDNA in Pancreatic Cancer Susan Tsai, MD, MHS
4: 00 PM AI-Derived Electronic Tumor Marker for Cancer Antigen 19-9 Nonproducers with Pancreatic Ductal Adenocarcinoma Anai Kothari, MD, MS
4:20 PM Questions
4:35 PM Closing Remarks Douglas B. Evans, MD

The Medical College of Wisconsin
8701 Watertown Plank Road
Hub for Collaborative Medicine; 1st Floor Conference Room A1015/1035
Milwaukee, WI 53226
United States
The Medical College of Wisconsin

The symposium will be held in Medical College of Wisconsin in the Hub for Collaborative Medicine-1st Floor Conference Room A1015/1035. Parking information will be provided to registered attendees ahead of the event.

Activity Director:
Y. David Seo, MD
 
MCW Speakers:
Douglas B. Evans, MD
Mandana Kamgar, MD, MPH
Tommy McFall, PhD
Y. David Seo, MD
Anai Kothari, MD, MS

 

Invited Speakers:
Wungki Park, MD, MS
Marcus Tan, MD
Susan Tsai, MD, MHS
 

 

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all persons in control of content must disclose any relevant financial relationships. It is the policy of the Medical College of Wisconsin to identify, mitigate and disclose the absence or presence of all relevant financial relationships with ineligible companies held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education. The following in control of content had no relevant financial relationships to disclose. 

  • Y. David Seo
  • Douglas Evans
  • Tommy McFall
  • Marcus Tan, MD
  • Susan Tsai
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed:
 
Name
Company
Role
Mandana Kamgar

Cornerstone Pharmaceuticals, 1Cell. AI, Astellas Pharma, Mirati Therapeutics, Bristol Myers Squibb, Elicio Therapeutics, AstraZeneca, Trishula Therapeutics, Daiichi Sankyo, Panbela Therapeutics

Research
Wungki Park

Astellas, Revolution Medicines, Innovent Biologics, Regeneron

Consultant, Advisory Committee

ACCME ACCREDITATION STATEMENT
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The Medical College of Wisconsin designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HOURS OF PARTICIPATION FOR ALLIED HEALTH CARE PROFESSIONALS
The Medical College of Wisconsin designates this activity for up to 3.75 hours of participation for continuing education for allied health professionals.

Available Credit

  • 3.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.75 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.